Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:37 PM
Ignite Modification Date:
2025-12-24 @ 6:37 PM
NCT ID:
NCT00313157
Eligibility Criteria:
Inclusion Criteria:
* Persistent or permanent atrial fibrillation with ventricular rate \> 80/min at rest and/or \> 100/min average at daytime.
* Male or female, age \> 18.
Exclusion Criteria:
* Hypersensitivity or contraindication to metoprolol, verapamil, diltiazem or carvedilol.
* Coronary heart disease or heart failure
* Systolic blood pressure \< 100 mmHg
* AV-conduction disturbance
* Severe hepatic or renal dysfunction
* Thyrotoxicosis
* Ongoing treatment with Digitalis
* Pregnancy or lactation
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00313157
Study Brief:
Protocol Section:
NCT00313157